Prime medicine to present at guggenheim healthcare talks – genomic medicines and rare disease days

Cambridge, mass., march 27, 2023 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that keith gottesdiener, m.d., president and chief executive officer of prime medicine, will present a corporate overview at the guggenheim healthcare talks – genomic medicines and rare disease days on monday, april 3, 2023 at 3:55 p.m. et in new york, ny.
PRME Ratings Summary
PRME Quant Ranking